JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 30, 2007; DOI: 10.1124/jpet.107.122242


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.122242v1
322/3/940    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Ahmet Bakan
Ivet Bahar
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazo, J. S.
Right arrow Articles by Brummond, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazo, J. S.
Right arrow Articles by Brummond, K. M.


Received for publication March 14, 2007.
Revised May 28, 2007.
Accepted for publication May 29, 2007.

Structurally Unique Inhibitors of Human Mitogen-activated Protein Kinase Phosphatase-1 Identified in a Pyrrole Carboxamide Library

John S. Lazo 1*, John J. Skoko 1, Stefan Werner 1, Branko Mitasev 1, Ahmet Bakan 1, Fumito Koizumi 1, Archibong Yellow-Duke 1, Ivet Bahar 1, Kay M. Brummond 1

1 University of Pittsburgh

* Address correspondence to: E-mail: lazo{at}pitt.edu

Abstract

Mitogen-activated protein kinase phosphatase 1 (MKP-1) is a tyrosine phosphatase superfamily member that dephosphorylates and inactivates cardinal mitogen-activated protein kinase (MAPK) substrates, such as p38, JNK, and Erk. Although these MAPK substrates regulate many essential cellular processes associated with human diseases, few pharmacological inhibitors have been described. The lack of readily available selective MKP-1 inhibitors has severely limited interrogation of its biological role and was one rationale for employing a recently described tricyclic pyrrole-2-carboxamide library in our screening efforts. In this report we demonstrate the pharmacological richness of the pyrrole carboxamide library by finding 10 of 172 members inhibited human MKP-1. Two of the pyrrole carboxamides, PSI2106 and MDF2085, were especially notable in vitro inhibitors of recombinant human MKP-1 enzyme activity with IC50 values of 8.0 ± 0.9 µM and 8.3 ± 0.8 µM, respectively. Both showed some selectivity for MKP-1 over the closely related phosphatases MKP-3, Cdc25B, VHR, and PTP1B. Computational examination of the surface properties near the catalytic site revealed that the studied phosphatases significantly differ in their electrostatic potential at the substrate binding site. The compounds inhibited MKP-1 reversibly but displayed mixed kinetics. Phosphatase inhibition was retained in the presence of physiologically relevant concentrations of glutathione. Molecular docking studies suggested PSI2106 may interact with His229 and Phe299 on MKP-1. These results reveal the power of using a small focused library for identifying pharmacological probes.


Key words: Protein tyrosine phosphatase, chemical probes, enzyme inhibition, mitogenic signaling, molecular docking, targeted chemical libraries


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
K. Przyklenk, M. Maynard, C. E. Darling, and P. Whittaker
Aging Mouse Hearts Are Refractory to Infarct Size Reduction With Post-Conditioning
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1393 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Vogt, P. R. McDonald, A. Tamewitz, R. P. Sikorski, P. Wipf, J. J. Skoko III, and J. S. Lazo
A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells
Mol. Cancer Ther., February 1, 2008; 7(2): 330 - 340.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.